olaparib (lynparza) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$11.8789 - $47.5158

VA Big4

$85.7193 - $87.0802

VA FSS

$111.9298

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
olaparib 100 mg (TABLET) $47.5158 AUS PBS generic
  • Lynparza (56)
  • AstraZeneca Pty Ltd
    olaparib 100 mg (TABLET) $86.4615 VA Big4
  • Lynparza (60)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 100 mg (TABLET) $87.0363 VA Big4
  • Lynparza (120)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 100 mg (TABLET) $111.9298 VA FSS
  • Lynparza (120)
  • ASTRAZENECA PHARMACEUTICALS LP
  • Lynparza (60)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 150 mg (TABLET) $47.5158 AUS PBS generic
  • Lynparza (56)
  • AstraZeneca Pty Ltd
    olaparib 150 mg (TABLET) $85.7193 VA Big4
  • Lynparza (60)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 150 mg (TABLET) $87.0802 VA Big4
  • Lynparza (120)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 150 mg (TABLET) $111.9298 VA FSS
  • Lynparza (120)
  • ASTRAZENECA PHARMACEUTICALS LP
  • Lynparza (60)
  • ASTRAZENECA PHARMACEUTICALS LP
    olaparib 50 mg (CAPSULE) $11.8789 AUS PBS generic
  • Lynparza (448)
  • AstraZeneca Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue